Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551

NCT00860353 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
90
Enrollment
INDUSTRY
Sponsor class

Stopped Due to portfolio and logistical issues, this study will not be re-started at the present time. The study is not being terminated for safety reasons.

Conditions

Interventions

Sponsor

AstraZeneca